91 results
8-K
TNFA
TNF Pharmaceuticals Inc.
17 Jun 24
Entry into a Material Definitive Agreement
9:04am
Biotechnologies (biosimilars) and is now the Executive Vice President of Research and Development and Chief Medical Officer of Invion LTD. Dr. Glass
8-K
EX-99.1
TNFA
TNF Pharmaceuticals Inc.
17 Jun 24
Entry into a Material Definitive Agreement
9:04am
pathways from early research and development to late-stage trials and market commercialization. His career highlights include 5 new drug applications
424B5
3ojoh6y 8rfhpo39t
17 Aug 22
Prospectus supplement for primary offering
3:00pm